Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 02, 2024 22:18 ET | Source: Portnoy Law

Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
December 15, 2023 19:03 ET | Source: Robbins LLP

OTLK STOCK ALERT: Robbins LLP Reminds Investors of January 2, 2024, Lead Plaintiff Deadline in the Class Action Filed Against Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
November 21, 2023 16:52 ET | Source: Robbins LLP

OTLK STOCK NEWS: Investors with Significant Losses in Outlook Therapeutics, Inc. Should Contact Robbins LLP for Information About the Outlook Therapeutics, Inc. Class Action

Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
November 16, 2023 10:34 ET | Source: Kaplan Fox & Kilsheimer LLP

OUTLOOK THERAPEUTICS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Outlook Therapeutics Investors of a Class Action Lawsuit and Upcoming Deadline

Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Outlook Therapeutics.
November 13, 2023 18:08 ET | Source: Robbins LLP

OTLK Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in the Outlook Therapeutics, Inc. Class Action

Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
November 07, 2023 13:03 ET | Source: Robbins LLP

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Outlook Therapeutics, Inc. (BCS)

Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
October 17, 2023 17:22 ET | Source: Portnoy Law

Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
October 11, 2023 17:49 ET | Source: Portnoy Law

Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....